Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

TSLP: from allergy to cancer.

Corren, Jonathan; Ziegler, Steven F.

Nat Immunol ; 20(12): 1603-1609, 2019 12.

Artigo em Inglês | MEDLINE | ID: mdl-31745338

2.

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

Menzies-Gow, Andrew; Corren, Jonathan; Bourdin, Arnaud; Chupp, Geoffrey; Israel, Elliot; Wechsler, Michael E; Brightling, Christopher E; Griffiths, Janet M; Hellqvist, Åsa; Bowen, Karin; Kaur, Primal; Almqvist, Gun; Ponnarambil, Sandhia; Colice, Gene.

N Engl J Med ; 384(19): 1800-1809, 2021 05 13.

Artigo em Inglês | MEDLINE | ID: mdl-33979488

3.

Tezepelumab in patients with allergic and eosinophilic asthma.

Caminati, Marco; Buhl, Roland; Corren, Jonathan; Hanania, Nicola A; Kim, Harold; Korn, Stephanie; Lommatzsch, Marek; Martin, Neil; Matucci, Andrea; Nasser, Shuaib M; Pavord, Ian D; Domingo, Christian.

Allergy ; 79(5): 1134-1145, 2024 May.

Artigo em Inglês | MEDLINE | ID: mdl-38146651

4.

Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy.

Wipperman, Matthew F; Gayvert, Kaitlyn M; Atanasio, Amanda; Wang, Claire Q; Corren, Jonathan; Covarrubias, Angelica; Setliff, Ian; Chio, Erica; Laws, Elizabeth; Wolfe, Kelley; Harel, Sivan; Maloney, Jennifer; Herman, Gary; Orengo, Jamie M; Lim, Wei Keat; Hamon, Sara C; Hamilton, Jennifer D; O'Brien, Meagan P.

Allergy ; 79(4): 894-907, 2024 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-38279910

5.

Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma.

Peters, Anju T; Sagara, Hironori; Corren, Jonathan; Domingo, Christian; Altincatal, Arman; Soler, Xavier; Pandit-Abid, Nami; Crikelair, Nora; Rowe, Paul J; Jacob-Nara, Juby A; Deniz, Yamo.

Ann Allergy Asthma Immunol ; 132(4): 477-484.e4, 2024 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-38013139

6.

Biomarkers and clinical outcomes after tezepelumab cessation: extended follow-up from the 2-year DESTINATION study.

Brightling, Christopher E; Caminati, Marco; Llanos, Jean-Pierre; Caveney, Scott; Kotalik, Ales; Griffiths, Janet M; Lundahl, Anna; Israel, Elliot; Pavord, Ian D; Wechsler, Michael E; Porsbjerg, Celeste; Corren, Jonathan; Golabek, Monika; Martin, Neil; Ponnarambil, Sandhia.

Ann Allergy Asthma Immunol ; 2024 Apr 30.

Artigo em Inglês | MEDLINE | ID: mdl-38697286

7.

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.

Corren, Jonathan; Menzies-Gow, Andrew; Chupp, Geoffrey; Israel, Elliot; Korn, Stephanie; Cook, Bill; Ambrose, Christopher S; Hellqvist, Åsa; Roseti, Stephanie L; Molfino, Nestor A; Llanos, Jean-Pierre; Martin, Neil; Bowen, Karin; Griffiths, Janet M; Parnes, Jane R; Colice, Gene.

Am J Respir Crit Care Med ; 208(1): 13-24, 2023 07 01.

Artigo em Inglês | MEDLINE | ID: mdl-37015033

8.

Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.

Corren, Jonathan; Larson, David; Altman, Matthew C; Segnitz, R Max; Avila, Pedro C; Greenberger, Paul A; Baroody, Fuad; Moss, Mark H; Nelson, Harold; Burbank, Allison J; Hernandez, Michelle L; Peden, David; Saini, Sarbjit; Tilles, Stephen; Hussain, Iftikhar; Whitehouse, Don; Qin, Tielin; Villarreal, Miguel; Sever, Michelle; Wheatley, Lisa M; Nepom, Gerald T; Sanda, Srinath.

J Allergy Clin Immunol ; 151(1): 192-201, 2023 01.

Artigo em Inglês | MEDLINE | ID: mdl-36223848

9.

Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study.

Corren, Jonathan; Ambrose, Christopher S; Griffiths, Janet M; Hellqvist, Åsa; Lindsley, Andrew W; Llanos, Jean-Pierre; Colice, Gene; Menzies-Gow, Andrew.

Clin Exp Allergy ; 53(4): 417-428, 2023 04.

Artigo em Inglês | MEDLINE | ID: mdl-36507576

10.

Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.

Corren, Jonathan; Hanania, Nicola A; Busse, William W; Sher, Lawrence D; Altincatal, Arman; Hardin, Megan; Mannent, Leda P; Amin, Nikhil; Lederer, David J; Soler, Xavier; Jacob-Nara, Juby A; Rowe, Paul J; Deniz, Yamo.

Clin Exp Allergy ; 53(10): 1020-1030, 2023 10.

Artigo em Inglês | MEDLINE | ID: mdl-37752621

11.

Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.

Papi, Alberto; Corren, Jonathan; Castro, Mario; Domingo, Christian; Rogers, Linda; Chapman, Kenneth R; Jackson, Daniel J; Daizadeh, Nadia; Pandit-Abid, Nami; Gall, Rebecca; Jacob-Nara, Juby A; Rowe, Paul J; Deniz, Yamo; Ortiz, Benjamin.

Allergy ; 78(1): 233-243, 2023 01.

Artigo em Inglês | MEDLINE | ID: mdl-35899469

12.

Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose.

Pavord, Ian D; Bourdin, Arnaud; Papi, Alberto; Domingo, Christian; Corren, Jonathan; Altincatal, Arman; Radwan, Amr; Pandit-Abid, Nami; Jacob-Nara, Juby A; Deniz, Yamo; Rowe, Paul J; Laws, Elizabeth; Lederer, David J; Hardin, Megan.

Allergy ; 78(11): 2921-2932, 2023 11.

Artigo em Inglês | MEDLINE | ID: mdl-37431558

13.

Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR study.

Menzies-Gow, Andrew; Bourdin, Arnaud; Chupp, Geoffrey; Israel, Elliot; Hellqvist, Åsa; Hunter, Gillian; Roseti, Stephanie L; Ambrose, Christopher S; Llanos, Jean-Pierre; Cook, Bill; Corren, Jonathan; Colice, Gene.

Ann Allergy Asthma Immunol ; 131(3): 343-348.e2, 2023 09.

Artigo em Inglês | MEDLINE | ID: mdl-37263380

14.

Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).

Pavord, Ian D; Hoyte, Flavia C L; Lindsley, Andrew W; Ambrose, Christopher S; Spahn, Joseph D; Roseti, Stephanie L; Cook, Bill; Griffiths, Janet M; Hellqvist, Åsa; Martin, Nicole; Llanos, Jean-Pierre; Martin, Neil; Colice, Gene; Corren, Jonathan.

Ann Allergy Asthma Immunol ; 131(5): 587-597.e3, 2023 11.

Artigo em Inglês | MEDLINE | ID: mdl-37619779

15.

Dupilumab long-term efficacy in patients with non-OCS-dependent asthma with and without evidence of allergic asthma.

Sher, Lawrence D; Corren, Jonathan; Pavord, Ian D; Daizadeh, Nadia; Altincatal, Arman; Soler, Xavier; Djandji, Michel; Radwan, Amr; Jacob-Nara, Juby A; Deniz, Yamo; Rowe, Paul J.

J Asthma ; 60(9): 1767-1774, 2023 09.

Artigo em Inglês | MEDLINE | ID: mdl-36876957

16.

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study.

Gevaert, Philippe; Saenz, Rebecca; Corren, Jonathan; Han, Joseph K; Mullol, Joaquim; Lee, Stella E; Ow, Randall A; Zhao, Rui; Howard, Monet; Wong, Kit; Islam, Lutaf; Ligueros-Saylan, Monica; Omachi, Theodore A; Bachert, Claus.

J Allergy Clin Immunol ; 149(3): 957-965.e3, 2022 03.

Artigo em Inglês | MEDLINE | ID: mdl-34530020

17.

Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.

Menzies-Gow, Andrew; Gurnell, Mark; Heaney, Liam G; Corren, Jonathan; Bel, Elisabeth H; Maspero, Jorge; Harrison, Timothy; Jackson, David J; Price, David; Lugogo, Njira; Kreindler, James; Burden, Annie; de Giorgio-Miller, Alex; Faison, Sarai; Padilla, Kelly; Martin, Ubaldo J; Garcia Gil, Esther.

Eur Respir J ; 60(6)2022 12.

Artigo em Inglês | MEDLINE | ID: mdl-35896216

18.

Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.

Corren, Jonathan; Pham, Tuyet-Hang; Garcia Gil, Esther; Salapa, Kinga; Ren, Pin; Parnes, Jane R; Colice, Gene; Griffiths, Janet M.

Allergy ; 77(6): 1786-1796, 2022 06.

Artigo em Inglês | MEDLINE | ID: mdl-34913186

19.

A real-world study of inhaled corticosteroid use in patients with severe eosinophilic asthma treated with mepolizumab.

Corren, Jonathan; Silver, Jared; Molfino, Nestor A; Bogart, Michael; Packnett, Elizabeth; McMorrow, Donna; Wu, Juan; Hahn, Beth.

Ann Allergy Asthma Immunol ; 128(2): 184-192.e1, 2022 02.

Artigo em Inglês | MEDLINE | ID: mdl-34774737

20.

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial.

Demoly, Pascal; Corren, Jonathan; Creticos, Peter; De Blay, Frédéric; Gevaert, Philippe; Hellings, Peter; Kowal, Krzysztof; Le Gall, Martine; Nenasheva, Natalia; Passalacqua, Giovanni; Pfaar, Oliver; Tortajada-Girbés, Miguel; Vidal, Carmen; Worm, Margitta; Casale, Thomas B.

J Allergy Clin Immunol ; 147(3): 1020-1030.e10, 2021 03.

Artigo em Inglês | MEDLINE | ID: mdl-32890575

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: